Immune regulation includes an effector arm: therapeutic implications of phase III IDO/PD-L1 vaccination in melanoma

Mads Hald Andersen

doi:10.1038/s41392-026-02993-x

Enriched recordOpen access

Immune regulation includes an effector arm: therapeutic implications of phase III IDO/PD-L1 vaccination in melanoma

Mads Hald Andersen

Signal Transduction and Targeted Therapy2026doi:10.1038/s41392-026-02993-x

Citation graph

Abstract

No public abstract is available from the verified source records.

Authors

Mads Hald Andersen#1

Institutions

University of Copenhagen Herlev Hospital

Provenance

crossref

Confidence 100%

pubmed

Confidence 98%

europepmc

Confidence 96%

openalex

Confidence 95%

doaj

Confidence 92%

datacite

Confidence 0%

Referenced works

View all references →

No local reference links have been materialized yet.

Cited by

View all cited-by records →

No local citing links have been materialized yet.

External reference records

10.1016/j.annonc.2026.04.010

10.1016/j.annonc.2026.04.010 · 2026

10.1038/s41467-025-67508-8

10.1038/s41467-025-67508-8 · 2026

10.1038/s41392-026-02710-8

10.1038/s41392-026-02710-8 · 2026

10.1200/jco.2026.44.16_suppl.9519

10.1200/jco.2026.44.16_suppl.9519 · 2026

10.1038/s41392-026-02626-3

10.1038/s41392-026-02626-3 · 2026

External cited-by records

10.1038/s41392-026-02626-3

10.1038/s41392-026-02626-3 · doi-reference

10.1200/jco.2026.44.16_suppl.9519

10.1200/jco.2026.44.16_suppl.9519 · doi-reference

10.1038/s41392-026-02710-8

10.1038/s41392-026-02710-8 · doi-reference

10.1038/s41467-025-67508-8

10.1038/s41467-025-67508-8 · doi-reference

10.1016/j.annonc.2026.04.010

10.1016/j.annonc.2026.04.010 · doi-reference